Search for: "Purdue Pharmaceuticals L.P. "
Results 21 - 40
of 61
Sorted by Relevance
|
Sort by Date
8 Feb 2019, 10:11 am
Right now, inside a Massachusetts federal courtroom, Massachusetts attorney general Maura Healey is up against pharmaceutical giant Purdue Pharma LP, maker of the controversial drug OxyContin, and its owners, the Sackler family. [read post]
18 May 2015, 1:14 pm
Purdue Pharma L.P., 2015 U.S. [read post]
14 Jun 2010, 6:12 pm
L.P. v. [read post]
7 Dec 2011, 11:32 am
Purdue Pharma, L.P., 343 F. [read post]
12 Dec 2011, 7:24 am
A Penalty that Includes Career Death: The former top executives and general counsel of Purdue Pharma L.P. are fighting their 12-year ban on working in the health care and pharmaceutical industries. [read post]
13 Nov 2007, 7:19 pm
The government's settlements with Bristol-Myers Squibb Co., Aventis Pharmaceuticals, Inc., Medco Health Solutions, Inc., Purdue Pharma L.P., Purdue Frederick Co., and InterMune, Inc. totalled over $800 million. [read post]
30 Oct 2018, 4:12 pm
There 80 towns and cities sued several major drug companies under RICO, including AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Janssen Pharmaceuticals Inc., among others, seeking damages over the opioid crisis. [read post]
8 Feb 2019, 10:26 am
Right now, inside a Massachusetts federal courtroom, Massachusetts attorney general Maura Healey is up against pharmaceutical giant Purdue Pharma LP, maker of the controversial drug OxyContin, and its owners, the Sackler family. [read post]
4 Aug 2022, 9:22 am
With AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Endo Pharmaceuticals Inc being sued previously. [read post]
18 Aug 2010, 12:19 am
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]
24 Jul 2012, 7:58 pm
Keating as a basis for the STOPP Act is the tamper-resistant version of Purdue Pharma L.P. [read post]
18 Sep 2016, 6:03 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 May 2010, 4:58 pm
Kappos (Orange Book Blog) (FDA Law Blog) OxyContin (Oxycodone) – US: Patent infringement suit following a Paragraph IV certification: Purdue Pharma L.P. et al v. [read post]
28 Oct 2014, 3:14 pm
Purdue Pharma L.P., 737 F.3d 908 (4th Cir. 2013). [read post]
5 May 2017, 9:28 am
Purdue Pharma L.P., 211 F.Supp.3d 1058 (N.D. [read post]
17 Feb 2010, 5:10 am
(IP Tango) Poland: differences in pharmaceutical trade marks (Class 46) South Africa: Court of the Commissioner of Patents: Interdict pends ‘pending’ decision: Sanofi v Cipla Medpro (Afro-IP) UK: Official UK patent law reports focus on SPCs (The SPC Blog) US: Pruning priority to prolong the patent – US patent covering ‘methods and compositions for stimulating the immune system’ (12:01 Tuesday) US: Bio sends letter on SACGHS Report to HHS Secretary Sebelius… [read post]
13 Sep 2023, 1:57 am
Purdue Pharma L.P., et al. [read post]
16 Jan 2017, 5:44 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
14 Nov 2016, 9:16 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
8 Feb 2017, 3:09 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
